Is it safe, is it tolerable? Why not ask the patients? - Editorial + NEJM link

"A thought-provoking perspective by oncologist Ethan Basch, published recently in the New England Journal of Medicine, highlighted the absence of any patient input into establishing a drug’s safety. This might seem surprising, given that distressing symptoms – which patients are best placed to report on – account for a large number of drug-related side-effects....cont'd

 NEJM:
The Missing Voice of Patients in Drug-Safety Reporting, by Ethan Basch, can be accessed at http://content.nejm.org/cgi/reprint/362/10/865.pdf